Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1Phase 1/2 1

Status

Recruiting 2Not yet recruiting 2Terminated 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Advanced Solid Tumors 69Advanced Solid Tumor 58Solid Tumor 50Solid Tumors 42Mesothelioma 40Mesothelioma, Malignant 37Hematopoietic and Lymphatic System Neoplasm 24Solid Tumor, Adult 16Ovarian Neoplasms 13Melanoma 13Malignant Solid Neoplasm 13Carcinoma, Non-Small-Cell Lung 13Sarcoma 11Pancreatic Neoplasms 11Retinoblastoma 10Colorectal Neoplasms 9Stomach Neoplasms 8Lung Neoplasms 8Advanced Malignant Solid Neoplasm 8Solid Tumours 7Small Cell Lung Carcinoma 7Cholangiocarcinoma 7Carcinoma, Renal Cell 7Advanced or Metastatic Solid Tumors 7Kidney Neoplasms 6Carcinoma, Hepatocellular 6Advanced/Metastatic Solid Tumors 6Advanced Malignant Solid Tumor 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5

Interventions

toripalimab 1Premedication 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumors × Other solid neoplasm × 90 days × Clear all
NCT07617727 2026-06-01

A Phase I Study of JSKN021 in Advanced Solid Tumors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 1 Not yet recruiting
199 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT07480733 2026-05-29

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 2 Recruiting
410 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT06573294 2026-05-20

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Genmab

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT07566247 2026-05-05

A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor

Akeso

Phase 1 Not yet recruiting
96 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT06499350 2026-03-10

A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors

FindCure Biosciences (ZhongShan) Co., Ltd.

Phase 1/2 Recruiting
33 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡